Genopole is reinforcing its cooperation with Biolake, a Chinese bioindustry based in Wuhan, the capitol of the Hubei province located approximately 850 kilometers west of Shanghai.
In 2013, Nutrivercell, an innovative leader in "nutritional synergies”, nearly doubled its turnover. For 2014, the company intends to continue its strong growth in the rapidly expanding food supplements market in France while also developing its sales abroad.
On August 22nd, an international consortium of more than 30 institutes, under the direction of the Genopole laboratories Inra-URGV (Plant Genomics Research Unit) and Genoscope-CEA, and in association with the CNRS and the University of Évry-Val-d’Essonne, published in the international journal Science a references sequence of Brassica napus, the main oil crop plant in Europe.
Metemis and Prestodiag : new successes for Genopole companies with the Innovation 2030 Worldwide Innovation Challenge And that makes seven for Genopole ! Following in the footsteps of Abolis Biotechnologies, Biométhodes, Osseomatrix, Magpie Polymers and Ynsect, two more Genopole companies, Metemis and Prestodiag, have become laureates of the Innovation 2030 Worldwide Innovation Challenge, a French initiative to support innovative companies in sectors with high economic potential. (...)
During the Genopole General Assembly held Friday September 26th, Isabelle This Saint-Jean, Vice-President of the Ile-de-France Regional Council in Charge of Higher Learning and Research, was elected as President of the biocluster. This Saint-Jean succeeds Thierry Mandon, who has held the position since the creation of Genopole in 1998. Mandon was recently named as French Minister of State reporting to the Prime Minister, with responsibility for State Reform and Administrative Streamlining, (...)
WatchFrog, a biotech company located on the Genopole campus in Évry, France, and specialized in the diagnosis of endocrine disruptors, recently published results for a new test demonstrating the antiandrogenic effects of pesticides highly present in the environment.
METAFORA biosystems, a Genopole-accredited company, announced the market launch of its unique cell metabolism biomarker, Glut1.RBD. This new tool intended for biomedical research offers a wide range of uses, from drug discovery and development to disease research, particularly in blood pathologies.
Anova-Plus at the heart of the battle against flavescence dorée, a disease that threatens european vineyards. Anova-Plus, an innovative start-up located on the Genopole campus in Évry, France, is developing a rapid diagnostic test for flavescence dorée, a serious and currently incurable phytoplasmic disease of grapevines. Viticulturists will be able to perform the DNA test themselves and thus quickly identify infected vine stocks. Scheduled for marketing in 2015, the test will help to limit (...)
Agdia-Biofords commercializes its firs rapid molecular diagnostic test to detect the pathogen responsible for little cherry disease Agdia-Biofords, a company located on the Genopole campus and an affiliate of the American company Agdia Inc., has made available a new rapid molecular diagnostic kit for the detection of the virus responsible for little cherry disease, which results in small, badly formed and insipid (...)
In synchronization with the International Endometriosis Awareness Week and the first Million Women March for Endometriosis held March 13th across the globe, the movement Lilli H Contre l’Endométriose (“Lilli H Against Endometriosis”) joined OZ2020, a first-ever endometriosis observatory launched in 2013 by Avenir Femmes Santé and Endodiag, a Genopole-accredited company specialized in the (...)